Adams–Oliver syndrome
(Redirected from Congenital scalp defects with distal limb reduction anomalies)
Adams–Oliver Syndrome (AOS) is a rare congenital disorder characterized by defects of the scalp and cranium (aplasia cutis congenita), transverse limb defects, and mottled skin appearance. First described in 1945 by Dr. Forrest H. Adams and Dr. Clarence Paul Oliver, AOS presents with a spectrum of clinical features that can vary significantly among affected individuals.
Epidemiology[edit | edit source]
AOS is an uncommon condition, with an estimated incidence of approximately 1 in 225,000 live births. It affects individuals of all genders and ethnic backgrounds equally. Due to its rarity, precise prevalence data are limited.
Clinical Features and Diagnosis[edit | edit source]
Major Clinical Features[edit | edit source]
- 1. Aplasia Cutis Congenita (ACC): Congenital absence of skin, typically on the scalp vertex, leading to localized areas devoid of skin and, in severe cases, underlying bone.
- 2. Limb Malformations: These may include:
- Syndactyly: Fusion of fingers or toes.
- Brachydactyly: Shortened digits.
- Oligodactyly: Missing fingers or toes.
- Hypoplastic or Absent Nails: Underdeveloped or missing nails.
Minor Clinical Features[edit | edit source]
- Cutis Marmorata Telangiectatica Congenita (CMTC): A vascular anomaly presenting as a reddish or purplish net-like pattern on the skin.
- Congenital Heart Defects: Structural anomalies of the heart present at birth.
- Vascular Anomalies: Including abnormalities in blood vessels, which can lead to complications such as pulmonary hypertension.
Diagnosis[edit | edit source]
The diagnosis of AOS is primarily clinical, based on the presence of characteristic features. A proposed diagnostic criterion includes:
- Major Criteria:
- Terminal transverse limb defects.
- Aplasia cutis congenita.
- Family history of AOS.
Minor Criteria:
- Cutis marmorata.
- Congenital heart defect.
- Vascular anomaly.
A diagnosis is considered definitive with the presence of two major criteria or one major and one minor criterion. Genetic testing can identify mutations in known associated genes, aiding in diagnosis, especially in atypical cases.
Genetic Basis and Pathophysiology[edit | edit source]
AOS exhibits genetic heterogeneity with both autosomal dominant and autosomal recessive inheritance patterns. Mutations in several genes have been implicated:
- ARHGAP31: Encodes a GTPase-activating protein involved in cytoskeletal organization.
- DOCK6: Functions as a guanine nucleotide exchange factor, regulating actin cytoskeleton dynamics.
- RBPJ, EOGT, NOTCH1, DLL4: These genes are components of the Notch signaling pathway, crucial for vascular development and cellular differentiation.
Disruptions in these genes affect vascular development and integrity, leading to the diverse manifestations of AOS.
Management and Prognosis[edit | edit source]
Management[edit | edit source]
Treatment is symptomatic and multidisciplinary:
- Scalp Defects: Management ranges from conservative care with dressings to surgical interventions like skin grafting, depending on severity.
- Limb Anomalies: Orthopedic interventions, including prosthetics or corrective surgeries, aim to improve function and appearance.
- Cardiac and Vascular Issues: Regular monitoring and appropriate medical or surgical treatments are essential for congenital heart defects and vascular anomalies.
Genetic counseling is recommended for affected families to discuss inheritance patterns, recurrence risks, and family planning options.
Prognosis[edit | edit source]
The prognosis for individuals with AOS varies based on the severity of manifestations. While many lead normal lives with appropriate management, severe cases involving significant cardiac or vascular anomalies may have increased morbidity and mortality risks. Early detection and a tailored, multidisciplinary approach are crucial for optimizing outcomes.
See Also[edit | edit source]
- Aplasia cutis congenita
- Cutis marmorata telangiectatica congenita
- Syndactyly
- Brachydactyly
- Notch signaling pathway
External links[edit | edit source]
Classification | |
---|---|
External resources |
|
NIH genetic and rare disease info[edit source]
Adams–Oliver syndrome is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD